Pharmaceuticals in the Netherlands

Pharmaceuticals in the Netherlands

Datamonitor's Pharmaceuticals in the Netherlands industry profile is an essential resource for top-level data and analysis covering the Netherlands industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of the industry’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of the industry

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by value and/or volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

* Market shares are covered by manufacturer or brand

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2007 annual average exchange rates.

The global figure comprises the Americas, Asia-Pacific and Europe.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Market Share 12
CHAPTER 6 Five Forces Analysis 13
6.1 Summary 13
6.2 Buyer Power 15
6.3 Supplier Power 16
6.4 New Entrants 18
6.5 Substitutes 20
6.6 Rivalry 21
CHAPTER 7 Leading Companies 22
7.1 AstraZeneca PLC 22
7.2 Pfizer Inc 25
7.3 GlaxoSmithKline Plc 28
CHAPTER 8 Market Forecasts 32
8.1 Market Value Forecast 32
CHAPTER 9 Macroeconomic Indicators 33
CHAPTER 10 Appendix 35
10.1 Methodology 35
10.2 Industry Associations 36
10.3 Related Datamonitor Research 36

LIST OF TABLES
Table 1: Netherlands Pharmaceuticals Market Value: $ million, 2004-2008 9
Table 2: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 10
Table 3: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 11
Table 4: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2008(e) 12
Table 5: Key Facts: AstraZeneca PLC 22
Table 6: Key Financials: AstraZeneca PLC 24
Table 7: Key Facts: Pfizer Inc 25
Table 8: Key Financials: Pfizer Inc 27
Table 9: Key Facts: GlaxoSmithKline Plc 28
Table 10: Key Financials: GlaxoSmithKline Plc 31
Table 11: Netherlands Pharmaceuticals Market Value Forecast: $ million, 2008-2013 32
Table 12: Netherlands Size of Population (million) , 2004-2008 33
Table 13: Netherlands GDP (Constant 2000 Prices, $ billion), 2004-2008 33
Table 14: Netherlands Inflation, 2004-2008 33
Table 15: Netherlands Exchange Rate, 2004-2008 34